Abstract: A process for manufacturing morphine-6-glucuronide and related compounds of the general structure of Formula 1:
wherein optionally substituted morphine is conjugated with an optionally substituted member of a new class of intermediates, namely, 1-haloglucuronate esters, in the presence of iodine or an iodinium compound. The conjugation may be followed by conversion of R1 of Formula 1 into hydrogen and/or the removal of the ester groups from the glucuronic residue at R2 of Formula 1.
Type:
Grant
Filed:
June 7, 2002
Date of Patent:
November 4, 2003
Assignee:
UFC Limited
Inventors:
Feodor Scheinmann, Andrew Valentine Stachulski, John Ferguson, Jane Louise Law